Bioxytran’s Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19
February 21, 2024 08:00 ET
|
BIOXYTRAN, INC.
First Medicinal chemistry of an antiviral drug made of sugars BOSTON, MASSACHUSETTS, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT), (the “Company”), a clinical stage biotechnology...
Radiation Dose Management Market Size Will Attain USD 7.77 Billion by 2030 Registering a Promising CAGR of 4.79% - Exclusive Report by Zion Market Research
September 25, 2023 14:40 ET
|
Zion Market Research
NEW YORK, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Radiation Dose Management Market By Modality (Computed Tomography,...